Petmed Express Inc  

(Public, NASDAQ:PETS)   Watch this stock  
Find more results for PETS
-0.06 (-0.44%)
Nov 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 13.46 - 13.75
52 week 12.07 - 16.83
Open 13.75
Vol / Avg. 118,811.00/218,162.00
Mkt cap 274.16M
P/E 16.20
Div/yield 0.17/5.03
EPS 0.84
Shares 20.26M
Beta 1.27
Inst. own 67%
Jan 19, 2015
Q3 2014 Petmed Express Inc Earnings Release (Estimated) - 8:00AM EST - Add to calendar
Oct 20, 2014
Q2 2014 Petmed Express Inc Earnings Call
Oct 20, 2014
Q2 2014 Petmed Express Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 4.75% 7.70%
Operating margin 7.45% 12.09%
EBITD margin - 12.46%
Return on average assets 13.25% 23.72%
Return on average equity 15.22% 26.78%
Employees 190 -
CDP Score - -


1441 SW 29 AVENUE
United States - Map
+1-954-9794788 (Phone)
+1-800-6008285 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


PetMed Express, Inc. (PetMed Express) and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Company markets its products through national television, online, and direct mail/print advertising campaigns. The Company offers a selection of products for dogs and cats. As of March 31, 2013, the Company�s product line contains approximately stock keeping units (SKUS). These products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution, and Rimadyl. It also offers for sale additional pet supplies on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers, and other pet supplies.

Officers and directors

Robert C. Schweitzer Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Menderes Akdag President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Bruce S. Rosenbloom Chief Financial Officer, Treasurer
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Frank J. Formica Independent Director
Age: 69
Bio & Compensation  - Reuters
Gian M. Fulgoni Independent Director
Age: 66
Bio & Compensation  - Reuters
Ronald J. Korn Independent Director
Age: 73
Bio & Compensation  - Reuters